logo
Plus   Neg
Share
Email

Surmodics Issues FY19 Outlook - Quick Facts

Surmodics, Inc. (SRDX) announced, for fiscal year 2019, the company expects non-GAAP result per share to be between a loss of $0.07 and profit of $0.23 per share. Revenue is expected to to range from $92 million to $97 million.

On a non-GAAP basis, earnings per share were $0.05 in the fourth quarter, as compared with $0.18 in the year-ago period. Total revenue was $23.0 million, as compared with $20.1 million in the prior-year period. Medical Device revenue was $17.0 million in the fourth quarter, compared with $14.7 million in the year-ago period, an increase of 15.4%, and included $2.2 million from SurVeil agreement with Abbott.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of Nordstrom Inc. (JWN) slipped 10 percent in extended hours on Thursday after the department store chain's full-year revenue outlook fell short of Street estimates. Seattle-based Nordstrom's third-quarter profit dropped to $67 million or $0.39 per share from $114 million or $0.67 per share... Shares of Nvidia Corp. (NVDA) plunged 16% in extended session on Thursday after chip designer's third-quarter revenues and fourth quarter outlook fell short of Wall Street estimates. Santa Clara, California-based Nvidia's third-quarter profit surged to $1.23 billion or $1.97 per share from $838 million... Retail giant Walmart Inc. on Thursday reported a 2 percent decrease in profit for the third quarter from last year as higher revenues were offset by one-time charges. However, adjusted earnings per share beat analysts' expectations, while revenue missed estimates. Looking ahead, the company lowered its outlook for fiscal 2019 reported earnings, but raised its outlook for adjusted earnings.
Follow RTT